Related Experiment Video
Updated: Dec 25, 2025
03:51
Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
Published on: December 8, 2023
4.1K
Dens evaginatus: Current treatment options.
Journal of the American Dental Association (1939)
|March 27, 2020
Summary
Dens evaginatus (DE) is increasingly seen in Western populations. Early diagnosis and treatment of DE teeth are crucial for preserving them, especially in young patients.
Area of Science:
- Dentistry
- Endodontics
- Dental Morphology
Background:
- Dens evaginatus (DE) is a developmental anomaly of teeth.
- DE prevalence is rising in Western countries due to increased Asian populations.
- Growing interest in DE is linked to advancements in regenerative endodontics.
Purpose of the Study:
- To present a narrative review of treatment options for teeth with dens evaginatus.
- To discuss treatment strategies based on pulpal status and tooth development stage.
Main Methods:
- A comprehensive literature search was conducted.
- Narrative review methodology was employed.
- Treatment options were analyzed based on clinical presentation.
Main Results:
- Treatment varies depending on pulpal and developmental status.
- Regenerative endodontics offers promising outcomes for immature teeth.
- Conservative management is often indicated for vital teeth.
Conclusions:
- Early detection of DE is vital for successful treatment.
- Tailored treatment approaches improve prognosis for DE teeth.
- Preservation of developing teeth with DE is achievable with timely intervention.
Related Concept Videos
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
117
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
117
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
363
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
363
01:29Venous Thrombosis III: Interprofessional Care
220
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
220
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
211
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
211
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
381
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
381